RM1 Project 1 - tAN Naloxone

Description

This two-visit, randomized, double-blind, sham-controlled trial, uses a novel naloxone blockade model in 136 individuals to determine whether the analgesic effects of a 30-minute transcutaneous auricular neurostimulation (tAN) intervention are mediated through a release of endogenous opioids. Analgesic effects of four various stimulation interventions will be measured (auricular vagus, auricular trigeminal, combination, or sham) while varying the type of intravenous (IV) infusion (either naloxone or saline) a participant is administered to determine whether the analgesic effects are mitigated by pharmacological opioid receptor blockade.

Conditions

Analgesia

Talk to us

Study Overview

On this page

Study Details

Study overview

This two-visit, randomized, double-blind, sham-controlled trial, uses a novel naloxone blockade model in 136 individuals to determine whether the analgesic effects of a 30-minute transcutaneous auricular neurostimulation (tAN) intervention are mediated through a release of endogenous opioids. Analgesic effects of four various stimulation interventions will be measured (auricular vagus, auricular trigeminal, combination, or sham) while varying the type of intravenous (IV) infusion (either naloxone or saline) a participant is administered to determine whether the analgesic effects are mitigated by pharmacological opioid receptor blockade.

Evaluating the Specific Role of Endogenous Opioids as the Mechanism Underlying tAN-based Analgesia in Healthy Individuals

RM1 Project 1 - tAN Naloxone

Condition
Analgesia
Intervention / Treatment

-

Contacts and Locations

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18-65
  • * Have the capacity and ability to provide one's own consent and sign the informed consent document
  • * Contraindicated for MRI.
  • * Any current or recent untreated medical, neurological, or psychiatric conditions
  • * Metal implant devices in the head, heart or neck.
  • * History of brain surgery.
  • * History of myocardial infarction or arrhythmia, bradycardia.
  • * Personal or family history of seizure or epilepsy or personal use of medications that substantially reduce seizure threshold (e.g., olanzapine, chlorpromazine, lithium).
  • * Personal history of head injury, concussion, or self-report of moderate to severe traumatic brain injury.
  • * Individuals suffering from frequent/severe headaches.
  • * Individuals with a reported history of psychosis or mania, or individuals who are actively manic or psychotic.
  • * Regular or recent pain medication use
  • * Moderate to severe alcohol or substance use disorder.
  • * Psychotropic or cardiac medicines that may interact with naloxone
  • * Positive urine drug screen for opiate use
  • * Females who are pregnant or lactating

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Medical University of South Carolina,

Study Record Dates

2027-10-01